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Background: Schizophrenia is a serious mental illness that levies a heavy medical toll and cost burden throughout
the world. Scientific collaborations are necessary for progress in psychiatric research. However, there have been few
publications on scientific collaborations in schizophrenia. The aim of this study was to investigate the extent of
author collaborations in schizophrenia research.
Methods: This study used 58,107 records on schizophrenia from 2003 to 2012 which were downloaded from
Science Citation Index Expanded (SCI Expanded) via Web of Science. CiteSpace III, an information visualization and
analysis software, was used to make a visual analysis.
Results: Collaborative author networks within the field of schizophrenia were determined using published
documents. We found that external author collaboration networks were more scattered while potential author
collaboration networks were more compact. Results from hierarchical clustering analysis showed that the main
collaborative field was genetic research in schizophrenia.
Conclusion: Based on the results, authors belonging to different institutions and in different countries should be
encouraged to collaborate in schizophrenia research. This will help researchers focus their studies on key issues, and
allow each other to offer reasonable suggestions for making polices and providing scientific evidence to effectively
diagnose, prevent, and cure schizophrenia.
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Schizophrenia is a serious mental disorder with a life-
time prevalence rate of 1% in the general population
worldwide. It is characterized by abnormal mental func-
tions and disturbed behaviors, which characteristically
appear as a series of clinical features, such as positive
and negative symptoms, and disturbances in basic cogni-
tive functions [1-6]. According to a recent survey of the
World Health Organization, it has been estimated that
mental disorder ranks the first in terms of disability ad-
justed life years (DALYs) and will surpass that of cardio-
vascular disease, respiratory disease, and malignant
tumors [7-9]. Thus, there is an immediate need to prevent
and treat schizophrenia. Given the enormous complexity
of this disease, it is particularly important that specialists
in psychiatry and neuroscience research, and scientists in* Correspondence: dzg52827@aliyun.com
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unless otherwise stated.the biomedical field in general, collaborate through re-
source sharing, exchange of ideas, knowledge dissemin-
ation, and information acquisition.
However, there have been very few studies on scientific
collaborations in schizophrenia research. In this study
we analyzed author collaboration relationships as a way
to help researchers focus their studies on key issues in
schizophrenia, in the hopes of helping them prevent and
treat this disease. An analysis of this sort can help clin-
ical and research departments select experts in the field
of schizophrenia, thus allowing research groups to im-
prove the efficiency of their research work and provide
scientific evidence and guidance for making policy.Methods
The dates for this study were taken from Science
Citation Index Expanded (SCI-Expanded) via the Web of
Science. The dates contained all documents which have
the word “schizophrenia” in the title, abstract, or keywords,l. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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documents included reviews, meeting abstracts, and man-
uscripts. There were a total of 58,107 records, each of
which contained a title, abstract, author names, institu-
tions, sources, and key words.
Authors’ collaboration relationships were usually re-
searched by using software such as SPSS and Pajek mainly
through dimension-reduced simplified algorithms which
were basically simple static first-generation InfoVis tech-
niques constrained by traditional tools and methods and
simple graphic processing and drawing. This study used
the most recent citation analysis and visualization software
called CiteSpace III (Edition 3.7), which is based on a
JAVA application. CiteSpace was invented by Dr. Chaomei
Chen (School of Information Science and Technology,
Drexel University, Philadelphia, PA, USA). Dr. Chen is an
international expert in the field of information visualiza-
tion. With the advantage of solid background of theor-
etical mathematics, computer science and computer
software and conversance with library literature infor-
mation, he firstly introduced Pathfinder—a kind of al-
gorithm that seeks the key path—into network analysis
and developed the CiteSpace series of application soft-
ware employing the second-generation InfoVis tech-
nique which are adapted to multivariate, time-sharing
and dynamic complex network analysis. By combining
InfoVis technique and scientometrics creatively, Chen
pioneered the comprehensive academic and applied
field of visualization with knowledge management to a
new stage of decision-making marked by the assistance
of domain mapping and knowledge visualization. The
CiteSpace series of utility software developed by Chen has
10,000 users in more than 36 countries and has become a
popular tool in scientometrics [10-12]. In CiteSpace III,
we specified the range of years to be analyzed, the length
of time slices within the time interval, and three sets of
threshold levels for citation counts, co-citation counts,
and co-citation coefficients. The specified thresholds were
applied to the earliest, middle, and last time slice, and lin-
ear interpolated thresholds which were assigned to the
remaining slices [13].
Results
Analysis of author external collaboration relationships
Firstly, the datasets for the analysis of schizophrenia
covering the time period from 2003 to 2012 were de-
veloped as a test bed for CiteSpace III. The lengths of
time were sliced into five parts, each of which was
2 years. The three sets of threshold levels for citation
counts, co-citation counts, and co-citation coefficients
were (12, 2, 15), (13, 3, 15), and (15, 3, 15), respect-
ively. Then, we selected an algorithm (Pathfinder) to
determine the path into the network analysis. In the
end, we chose corresponding nodes of networks andformed a citation network of authors in the field of
schizophrenia (Figure 1). In this visualization, the node
size represents the overall frequency of occurrence of
authors, and the colored rings of the nodes represent
yearly time-slices.
Table 1 lists the top 10 authors with regard to occur-
rence frequency in a collaborative network. For example,
Norio Ozaki, Daniel R. Weinberger, Nokao Iwata, and
MS Keshavan all focused on genetic research in schizo-
phrenia. Norio Ozaki had the highest author occurrence
frequency, and the paper with the highest citation fre-
quency was one titled “Serotonin transporter missense
mutation association with complex neuropsychiatric
phenotype” published in 2003. The main research field
of John M Kane and Daniel C. Javitt was drug treatment
of schizophrenia. The highest citation frequency paper
was titled “Tardive dyskinesia- prevalence and risk factor,
1959 to 1979” published in 1982 and “Recent advances
in the phencyclidine model of schizophrenia” published
in 1991, respectively. Jeffrey A. Lieberman’s field of re-
search was nerve impulses in schizophrenia, and the
paper with the highest citation frequency was one titled
“Provocative tests with pycho-stimulant drugs in schizo-
phrenia” published in 1987. The author Christos Pantelis
conducted research in symptoms of schizophrenia, and
the paper with the highest citation frequency was one ti-
tled “Neuroanatomical abnormalities before and after
onset of psychosis: across-sectional and longitudinal
MRI comparison” published in 2003. Robin M. Murray’s
field of work was epidemiologic study on schizophrenia,
and the highest citation frequency paper was titled “Is
schizophrenia a neurodevelopmental disorder” published
in 1987. Rene S. Kahn focused on neurochemistry of
schizophrenia, and the highest citation frequency paper
was “Metachlorophenylpiperazine as a probe of sero-
tonin function” published in 1991.
Hierarchical clustering analysis is widely used in ana-
lyses of collaborative networks. The authors who have
frequency of occurrence which surpass the threshold are
called core authors who have a large impact on similar
authors. Through hierarchal clustering, we found 32
sub-networks. Figure 2 was a map of 32 clusters and the
results were listed in Table 2. Sub-network 29 was the
biggest sub-network, including 91 authors mainly concen-
trated on genetic research of schizophrenia. There were
also seven sub-networks focused on genetic research of
schizophrenia. Genetic research on the Chinese Han
population was the most favored collaborative field in
sub-networks 4 and 8, led by authors Lin He and GuoYing
Feng, respectively. Sub-network 9 led by KS Kendler con-
centrated on schizophrenia genetic research of the Irish
population. Sub-network 27 led by JJ Kim concentrated
on genetic research of the Korean population. Sub-
network 15 led by YuTao Xiang concentrated on genetic
Figures 1 Collaborative network of authors in schizophrenia field.
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the regional features and genetic heterogeneity were most
clear. Sub-network 13 and sub-network 26 focused on
genetic research of schizophrenia as their main subject,
led by authors W Maier and MJ Owen, respectively.
Table 2 showed that sub-network 12 led by A Weizman,
sub-network 16 led by R Marcus, sub-network 17 led by
Larry J. Seidman, sub-network 22 led by John M Kane,
and sub-network 24 led by Jeffry A. Lieberman, concen-
trated on drug treatment for schizophrenia. However, theyTable 1 Top 10 authors’ frequency in collaborative network
Rank Frequency Author
1 70 Norio Ozaki
2 69 Daniel R. Weinberger
3 63 Jeffrey A. Lieberman
4 60 Christos Pantelis
5 60 Nakao Iwata
6 60 Robin M. Murray
7 59 John M. Kane
8 58 MS Keshavan
9 57 Rene S. Kahn
10 56 Daniel C. Javittnever collaborated with each other on the topic. Similarly,
sub-network 11 led by RE Gur, sub-network 14 led by MF
Green, and sub-network 31 led by Philip D. Harvey focused
on cognitive disorder in schizophrenia, and never collabo-
rated with each other on the topic. The main field of sub-
network 25, led by MT Tsuang, and sub-network 28 led by
DL Braff was transmission of nerve impulse in schizophre-
nia. The topic of sub-network 3 led by EC Johntone and
sub-network 10 led by RW McCarley was brain imaging
in schizophrenia. The main collaborative field of sub-
network 6, led by Cynthia Shannon Weickert, and sub-
network 7 led by MS Keshavan was biochemical study on
schizophrenia. Both sub–network 20 led by Christos
Pantelis and sub-network 23 led by HanJuergen Moeller
focused on symptoms of schizophrenia as their main sub-
ject. Sub-network 0 led by AW Toga and sub-network 19
led by PD Harvey concentrated on schizophrenia in
childhood and adolescence. Sub-network 21 led by DR
Weinberger and sub-network 30 led by S Frangon fo-
cused on neurochemistry in schizophrenia. Sub-network
1 led by Robin M. Murray centered on the epidemiology
of schizophrenia. Sub-network 2 led by JM Gold con-
centrated on clinical assessment. Sub–network 5 led by
Tyrone D. Cannon focused on etiology and pathogenesis
of schizophrenia. The focus of sub-network 18 was
Figures 2 External authors’ collaborative fields of different sub-networks.
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J Klosterkotter.
Analysis of author potential collaboration relationships
We found potential collaboration relationships through
co-citation analysis in the author collaborative network.
The source of date was unchanged and the three sets of
threshold levels for citation counts, co-citation counts,
and co-citation coefficients were (40, 3, 20), (42, 4, 20),
and (45, 5, 20), respectively. Then Pathfinder was used
to determine the key path into the network analysis. We
chose corresponding nodes of networks and formed a
co-citation network of authors in the field of schizophre-
nia (Figure 3). In this manner, the authors who had the
same research direction were connected together by au-
thor co-citation analysis; although in reality they may
never have collaborated on a publication. The authors’
relationships has transformed from collaborating to pub-
lish a thesis into research direction.
We have listed the top 10 authors of co-citation fre-
quency in Table 3. The highest co-citation frequency au-
thor was the American Psychiatric Association, which is
the main professional organization for psychiatrists and
trainee psychiatrists in the United States, and the largest
psychiatry organization in the world. Its 36,000 members
are mainly American, but some are also from othercountries. The association has published various journals
and pamphlets, as well as the Diagnostic and Statistical
Manual of Mental Disorders, which codifies psychiatric
conditions and is used worldwide as a key guide for
diagnosing mental disorders. The highest citation fre-
quency among its paper was “Reporting standards for re-
search in psychology: Why do we need them? What
might they be?” published in 2008. The second co-
citation frequency author was Kay SR, who conducted
research into the diagnosis of schizophrenia. The paper
with the highest citation frequency among this author’s
works was titled “The positive and negative syndrome
scale (PANSS) for schizophrenia” published in 1987.
This paper compiled the Positive and Negative Syn-
drome Scale. In 1990, Kay SR also introduced five of the
axis symptoms of schizophrenia, including negative
symptoms, positive symptoms, anxiety, depression, and
cognitive problems. Since then, there has been closer at-
tention on the cognitive symptoms of schizophrenia.
The third co-citation frequency author was Andreasen
NC who focused on the symptoms of schizophrenia. The
title of the paper with the highest citation frequency for
this author was “Family history method using diagnostic
criteria-reliability and validity” published in 1977. The au-
thor Green MF focused on cognitive disorders of schizo-
phrenia, and the title of the paper with the highest citation
Table 2 External collaborative sub-network of authors
Sub-network Number of authors Core author Cluster top term The main collaborative field
0 2 AW Toga Childhood-onset schizophrenia Study in childhood and adolescence
1 2 Robin M. Murray Putative endophenotype Epidemiologic study
2 2 JM Gold Repeatable battery Clinical assessment
3 2 EC Johnstone Voxel-based morphometry Etiology and pathogenesis
4 2 Lin He Chinese population Genetic research of Chinese Han population
5 2 Tyrone D. Cannon Psychosis Brain imaging
6 3 Cynthia Shannon Weickert Emotional word Biochemical study
7 2 MS Keshavan Antipsychotic-native patient Biochemical study
8 2 GouYing Feng Chinese Han Genetic research of Chinese Han population
9 2 KS Kendler Irish study Genetic research of Irishman
10 2 RW McCarley DTI Brain imaging
11 3 RE Gur Recognition Cognitive disorders
12 3 A Weizman Management Drug treatment
13 4 W Maier Dysbindin Gene research
14 3 MF Green Recent-onset Cognitive disorders
15 2 YuTao Xiang Asian patient Genetic research of Southeast Asian
16 3 R Marcus Aripiprazole Drug treatment
17 4 Larry J. Seidman Schizophrenia Drug treatment
18 2 J Klosterkotter Adult version Substance-related study
19 5 PD Harvey Risk Childhood schizophrenia disorders
20 7 Christos Pantelis Taste Psychopathology
21 7 DR Weinberger Schizophrenia Neurochemistry
22 5 John M. Kane Antipsychotic drug Drug treatment
23 10 HansJuergen Moeller Adverse event Psychopathology
24 3 Jeffrey A. Lieberman Association study Drug treatment
25 2 MT Tsuang Schizophrenia Transmission of nerve impulses
26 4 MJ Owen Polymorphism Genetic research
27 4 JJ Kim Korean population Genetic research of Korean
28 2 DL Braff Mismatch Transmission of nerve impulses
29 91 Norio Ozaki Schizophrenia Genetic research of Japanese
30 2 S Frangon Early onset schizophrenia Neurochemistry
31 2 Philip D. Harvey Schizophrenia Cognitive disorders
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neurocognitive deficits in schizophrenia” published in
1996. Meltzer HY and Kapur S focused on drug treatment
in schizophrenia. The highest citation frequency paper
was titled “Classification of typical and atypical anti-
psychotic drugs on the basis of dopamine D-1, D-2 and
serotonin 2 pki values” published in 1989 and “Psychosis
as a state of aberrant salience: a framework linking biol-
ogy, phenomenology, and pharmacology in schizophrenia”
published in 2003, respectively. Harrison PJ concentrated
on genetic research in schizophrenia and the highest cit-
ation frequency paper was “Schizophrenia genes, gene ex-
pression, and neuropathology: on the matter of theirconvergence” published in 2005. Wechsler D was a fam-
ous American psychologist and compiled the Wechsler
Adult Intelligence Scale. The paper with the highest cit-
ation frequency for Wechsler D was “A standardized
memory scale for clinical use” published in 1945. The
authors Weinberger and Lieberman appeared in both
Tables 1 and 3.
In order to further detect the potential author collab-
oration relationships, we found 12 sub-networks through
hierarchal clustering. Figure 4 was a map of 14 clusters,
and the results were listed in Table 4, which showed that
sub-network 4 led by Stefanson H and sub-network 5
led by Kendler KS concentrated on genetic research on
Figure 3 Co-citation network of authors in schizophrenia field.
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network 3 led by Green MF, and sub-network 8 led by
Braff DL all focused on cognitive disorders of schizo-
phrenia as their main subject. Diagnosis of schizophrenia
was the focus of research in sub-network 0 led by
Kraepelin E and sub-network 1 led by Van Os J. Javitt DC
and Weinberger DR led sub-network 7 and sub-network 9
to focus on neurochemistry of schizophrenia, respectively.
Symptoms of schizophrenia was the main topic of sub-
network 10 led by Andreasen NC and sub-network 13 ledTable 3 Top 10 authors’ frequency in co-citation network
Rank Frequency Author
1 2341 American Psychiatric Association
2 2079 Kay SR
3 1970 Andreasen NC
4 1369 Lieberman JA
5 1137 Green MF
6 1073 Weinberger DR
7 1036 Meltzer HY
8 926 Harrison PJ
9 834 Wechsler D
10 822 Kapur Sby Spitzer RL. As the central author in sub-network 6,
Lewis DA concentrated on the etiology and pathology of
schizophrenia. The American Psychiatric Association fo-
cused on the prognosis of schizophrenia in sub-network
11. The main research field of sub-network 12 was drug
treatment for schizophrenia led by Lieberman JA.
Discussion
In this study, we developed an author collaboration net-
work for schizophrenia studies during dates ranging
from 2003 to 2012 by using visualization technology.
Our findings indicated that genetic research for schizo-
phrenia was a very active and intense area of collabora-
tive research. Schizophrenia is a complex mental disease
[14], and genetics plays a key role in its pathogenicity,
with a heritability factor of 0.70–0.85 [15-19]. Genetic
inheritance of schizophrenia does not follow a Mendelian
pattern. Genetic investigations focused on the elements of
consanguinity, adoption, and monozygotic multiple births,
and these investigations have shown that genetic inherit-
ance is a major cause of schizophrenia. Thus, collaborative
research has focused on finding susceptibility genes for
schizophrenia. There is active research on finding the
genes that correspond to the specific clinical symptoms of
schizophrenia, which can help in providing personalized
treatments based on one’s genotype [20,21].
Figures 4 Potential authors’ collaborative fields of different sub-networks.
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found that the structure of the network was looser and
there were fewer relationships among authors who
belonged to different institutions in different countries.
This indicated that collaborative networks typically
tended to be within the same institution or in the sameTable 4 Potential collaborative sub-network of authors
Sub-network Number of authors Core author C
0 2 Kraepelin E G
1 14 Van Os J D
2 12 Cannon TD D
3 18 Green MF C
4 10 Stefansson H C
5 11 Kendler KS S
6 8 Lewis DA C
7 12 Javitt DC S
8 8 Braff DL P
9 14 Weinberger DR T
10 19 Andreasen NC D
11 12 American Psychiatric Association 6
12 64 Lieberman JA N
13 2 Spitzer RL Acountry or region. Because the level of scientific research
is closely related with the rate of economic development,
different countries have different scientific research
levels. If the development of scientific collaborations
among authors is confined to their own country, it is no
surprise that polarization occurs, such that scientificluster top term The main collaborative field
erman-speaking psychiatry Diagnostic standard
etection strategy Diagnostic standard
yslexia Cognitive disorder
linical pharmacology/trials Cognitive disorder
opy-number variation Genetic research
chizophrenia susceptibility gene Genetic research
ortical interneuron development Etiology and pathology
tructure activity relationship Neurochemistry
erceived spatial separation Cognitive disorder
remor Neurochemistry
iffusion-weighted MRI Brain damage symptoms
-week Prognosis
onfasting triglycerides Drug treatment
NK3 The positive and negative symptoms
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and lower in economically less-developed countries. This
can prevent scientific research on schizophrenia to some
extent. Thus, we should encourage collaboration among
institutions and countries in order to promote coordi-
nated development of international scientific research in
schizophrenia.
In the authors’ potential collaborative network, we
found that the structure of the network was more com-
pact, which indicated that the research theme was rela-
tively centralized and the collaborative relationship is
stronger, allowing for collaborative publications focused
on genetics, cognitive symptoms, and brain imaging for
schizophrenia. However, researchers in the same field
have a disincentive to collaborate and exchange know-
ledge because they are unable to know and communi-
cate directly each other. Thus, the purpose of this study
was to help with the exchange of ideas and strengthen
communication between schizophrenia researchers to
bolster research in this area.
The fact that Weinberger and Lieberman appeared in
both the external collaboration network and potential
collaboration network showed that these two researchers
were not only prolific authors, but also published clas-
sical works which had great influence amongst their
peers. They had made outstanding contributions in the
field of schizophrenia research in the past 10 years.Conclusions
In recent years, schizophrenia research has become one
of the most popular areas in the field of psychiatry. With
the coming of biological information time, more and
more researchers begin to find the necessity of scientific
collaboration which not only is beneficial to sharing of
ability and technology but also spreading of new know-
ledge, ability and technology and the production of new
ideas, especially improved research production and influ-
ence of researchers. In this study we chose visualization
technology to analyze author collaboration relationships
in the field of schizophrenia so that leaders in the field can
produce effective research groups, improve the efficiency
of research work, and provide a basis for making policy.
Furthermore, our findings may help in developing strat-
egies for finding the etiology and pathogenesis of schizo-
phrenia and help with clinical diagnosis and treatment.
Future studies from our groups will use visualization
technology to track other branches in schizophrenia re-
search, such as genome association studies, in order to
acquire more valuable information and promote rapid
development of this area.Competing interests
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